Erste Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Erste Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-35,500	Closed	-$1.83M	–	601
2022 Q3	$1.83M	Hold	35,500	–	–	0.04%	292
2022 Q2	$905K	Hold	35,500	–	–	0.02%	366
2022 Q1	$888K	Buy	35,500 +19,000	+115%	+$534K	0.02%	368
2021 Q4	$598K	Hold	16,500	–	–	0.01%	414
2021 Q3	$323K	Sell	16,500 -43,500	-73%	-$678K	0.01%	450
2021 Q2	$845K	Hold	60,000	–	–	0.02%	360
2021 Q1	$2.99M	Hold	60,000	–	–	0.07%	227
2020 Q4	$3.69M	Sell	60,000 -15,000	-20%	-$859K	0.1%	195
2020 Q3	$4.01M	Buy	75,000 +7,000	+10%	+$377K	0.14%	169
2020 Q2	$3.72M	Hold	68,000	–	–	0.15%	155
2020 Q1	$2.69M	Hold	68,000	–	–	0.16%	158
2019 Q4	$2.46M	Buy	+68,000	New	+$1.19M	0.11%	186

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Erste Asset Management's CCXI Position: Q4 2022 in Review

Erste Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 35,500 shares — an estimated $1.83M sold.

Erste Asset Management first reported a position in CCXI in Q4 2019 and held it in 12 quarters. The position peaked at $4.01M in Q3 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Erste Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Erste Asset Management sold 35,500 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1.83M.
Erste Asset Management first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 12 quarters.
Erste Asset Management's ChemoCentryx, Inc. position peaked at $4.01M in Q3 2020.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Erste Asset Management's 13F filing for Q4 2022, filed 26 Nov 2024.